The Complete Streets Act of 2025 requires states to establish programs that help local governments, transit agencies, Tribal governments, and other eligible entities design and build transportation infrastructure accommodating all users - including pedestrians, cyclists, transit riders, and people with disabilities. States must provide technical assistance and grants for complete streets projects, with funding coming from 5% of transportation funds apportioned to each state. The bill establishes new design standards requiring protected bike lanes, accessible sidewalks, and appropriate lighting for many road projects, with compliance required for certain new construction and reconstruction projects on Federal-aid highways within metropolitan areas. It also mandates that states develop "complete streets prioritization plans" focusing on improving safety, mobility, and accessibility, particularly in underserved communities.
HR 649, the Whole Milk for Healthy Kids Act of 2025, amends the National School Lunch Act to allow schools participating in the program to offer students both organic and non-organic whole milk, in addition to reduced-fat, low-fat, and fat-free options. Key provisions include clarifying that milk fat in whole milk should not count toward saturated fat limits for meal compliance, prohibiting schools from purchasing milk from Chinese state-owned enterprises, and ensuring schools cannot be barred from offering the full range of milk types listed. The bill directly affects public and private schools serving the National School Lunch Program by expanding their milk options for students. It focuses on concrete policy changes to dietary offerings and sourcing restrictions within the school nutrition program.
HRES 478 is a symbolic House resolution designating the month of July as "American Patriotism Month." It does not create new laws or policies but encourages voluntary observance through ceremonies, educational activities, and community events celebrating American history and values. The resolution highlights historical events like Independence Day, Pearl Harbor, and 9/11 as examples of patriotism, while urging schools, organizations, and communities to participate in commemorations. It has no binding effect on citizens or government operations and merely requests the President issue an annual proclamation. This is purely a ceremonial recognition with no direct impact on individuals or policy implementation.
HRES 473 is a non-binding House resolution calling on the U.S. government to urgently use diplomatic efforts to ensure food and medical supplies reach civilians in Gaza. It directly addresses the needs of approximately 2.2 million Palestinians facing acute hunger, including 10,000 children identified with acute malnutrition, following a border blockade that blocked aid from March to May 2025. The resolution specifically urges the White House and State Department to secure "immediate and secure delivery and disbursement" of aid and a lasting end to the conflict, citing collapsed bakeries, exhausted food rations, and a near-total health system collapse.
HRES 472 is a symbolic House resolution condemning an antisemitic terrorist attack in Boulder, Colorado, on June 1, 2025, which targeted Jewish individuals. The resolution explicitly condemns the attack - where the perpetrator used Molotov cocktails against victims aged 52-88, including a Holocaust survivor - and calls for prosecuting the perpetrator. It also expresses concern about rising antisemitism on campuses and online, while urging Congress to secure borders and deport visa overstayers (though this is a symbolic call, not a new law). The resolution directly affects the Boulder Jewish community and victims of the attack, with no new policy changes enacted.
HRES 475 (June 4, 2025) is a non-binding resolution that formally recognizes "Family Month" and ends the House of Representatives' recognition of Pride Month. It directs the House to "recognize the benefit of marriage and family" while stating it "no longer recognizes Pride Month," citing the resolution's view that traditional nuclear families are essential to society. The resolution does not create new laws or policies but changes the House's official acknowledgment of months. It specifically targets the House's ceremonial recognition, not federal law or programs affecting citizens. This is a symbolic procedural action with no direct impact on legislation or constituents.
HRES 468 designates June 1-7, 2025, as "National Trailer Safety Week" in the U.S. to promote education about safe towing practices for light- and medium-duty trailers. The resolution supports existing efforts by the National Association of Trailer Manufacturers to educate American motorists on proper trailer maintenance, inspection, and towing techniques. It does not create new laws but expresses congressional backing for this annual awareness campaign, which aims to reduce road incidents by engaging dealers, manufacturers, and end-users. The initiative directly targets motorists who tow trailers, aligning with a program that reaches hundreds of thousands annually.
This bill, the Protecting Law Enforcement from Doxxing Act (S 1952), makes it a federal crime to publicly release a federal law enforcement officer's name with the intent to obstruct criminal investigations or immigration enforcement operations. It defines "federal law enforcement officer" broadly to include anyone authorized to prevent, detect, investigate, or prosecute federal criminal or immigration violations. Violators face penalties including fines, up to five years in prison, or both. The law directly affects federal officers and individuals who disclose their names with obstructive intent, while updating related sections of federal law to include this new prohibition.
This bill (S 1949) creates new penalties for manufacturing or distributing candy-flavored drugs marketed to minors. It specifically targets producers who combine schedule I or II controlled substances with candy/beverage products, market them to appear like candy, or modify them with candy-like flavors/coloring, knowing they’ll be sold to people under 18. First offenses carry up to 10 additional years in prison, while repeat offenses carry up to 20 additional years. Exceptions apply for FDA-approved medications sold as prescribed and products altered under a doctor’s direction for legitimate medical use.
This bill, titled "Make DOGE Permanent Act," amends the Federal Funding Accountability and Transparency Act of 2006 to provide Members of Congress (Senators and Representatives) with real-time access to federal award data. It requires the Office of Management and Budget to create a secure, separate online link for Congress to view updated information on federal spending, including payments to individual recipients and federal employees. The website must update in real time for this access, and the link must be established within six months of enactment. The bill directly affects congressional oversight capabilities but does not change public access to the same data.
The Family Vaccine Protection Act makes the Advisory Committee on Immunization Practices (ACIP) an official part of federal law, requiring it to provide vaccine recommendations based on strong scientific evidence. It mandates that the CDC Director must adopt ACIP's recommendations unless they don't meet the evidence standard, and if not adopted, the CDC must explain its decision and notify Congress within 48 hours. The bill establishes procedures for ACIP to review new vaccines within 90 days of licensure and to consider breakthrough therapies or public health emergencies. This act aims to strengthen transparency and evidence-based decision-making in vaccine recommendations for the public health system. It affects the CDC, ACIP, and Congress through formalized processes for vaccine policy development.
This bill creates an exception for certain small biotech companies from Medicare's drug price negotiation program starting in 2029. It applies to "research and development-intensive small biotech manufacturers" that invest a specific percentage (30%-70%) of their net revenue in R&D over the prior three years and have 5 or fewer qualifying single-source drugs. To qualify, companies must annually submit financial data to Medicare proving their R&D spending meets the threshold. This directly affects small U.S.-based biotech firms developing innovative drugs, allowing them to avoid price negotiations under Medicare for qualifying products.
